What are examples of combination medications that include an Angiotensin-Converting Enzyme (ACE) inhibitor and a calcium channel blocker?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ACE Inhibitor and Calcium Channel Blocker Combination Medications

The most effective combination medications containing an ACE inhibitor and a calcium channel blocker include perindopril/amlodipine, lisinopril/amlodipine, benazepril/amlodipine, trandolapril/verapamil, and enalapril/felodipine. 1

Available Combination Products

  • Perindopril/amlodipine - A fixed-dose combination that has shown optimal results in clinical studies, particularly beneficial for patients with uncontrolled hypertension or cardiovascular risk factors 2
  • Benazepril/amlodipine - One of the most widely used combinations, available in various dosage strengths 1
  • Trandolapril/verapamil - Combines an ACE inhibitor with a non-dihydropyridine calcium channel blocker 1
  • Lisinopril/amlodipine - Effective combination for hypertension management 1
  • Enalapril/felodipine - Another available fixed-dose combination 1

Therapeutic Rationale

  • The combination of an ACE inhibitor and a calcium channel blocker provides complementary mechanisms of action, resulting in additive blood pressure lowering effects 1
  • This combination is specifically recommended by major guidelines as one of the preferred combinations for hypertension management due to its effectiveness in reducing cardiovascular events 3
  • Fixed-dose combinations improve medication adherence by reducing the number of pills taken by patients 3, 2
  • The combination targets different blood pressure control systems, creating a synergistic effect 1, 4

Clinical Evidence Supporting This Combination

  • The European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines specifically recommend ACE inhibitor + calcium channel blocker as an effective two-drug combination for hypertension management 3
  • This combination has been shown to reduce cardiovascular events more effectively than some other combinations, with a synergistic effect on blood pressure control 1, 5
  • In patients with resistant hypertension, a triple drug regimen of an ACE inhibitor, calcium channel blocker, and a thiazide diuretic is effective and generally well tolerated 3

Important Considerations

  • Dihydropyridine CCBs (like amlodipine) are most commonly combined with ACE inhibitors, while non-dihydropyridine CCBs (like verapamil, diltiazem) can also be used with ACE inhibitors, though they have different side effect profiles 1
  • The combination may improve endothelial function more than either agent alone, potentially leading to better cardiovascular outcomes than a diuretic/ACE inhibitor combination 5
  • This combination is particularly beneficial for patients with diabetes mellitus, metabolic syndrome, or higher cardiovascular risk 2

Contraindications and Cautions

  • Non-dihydropyridine calcium channel blockers (verapamil and diltiazem) should be avoided in patients with heart failure 3
  • Blood pressure should be monitored closely after starting this combination, especially during the first month of therapy 1
  • Avoid combining an ACE inhibitor with an angiotensin receptor blocker (ARB), as this combination increases cardiovascular and renal risk without additional benefit 6

Special Populations

  • This combination is recommended for patients with diabetes, chronic kidney disease with albuminuria, or high cardiovascular risk 1
  • The combination is appropriate for Black patients after initial therapy, and for elderly patients, but with careful monitoring and dose adjustment 1
  • In hypertensive animal models, the combination of verapamil and trandolapril has been shown to normalize endothelial dysfunction 4
  • The combination therapy has shown additive preventive effects on hypertensive heart failure with preserved systolic function in experimental models 7

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.